A Phase I Clinical Trial of Sequential Pralatrexate Followed by a 48-hour Infusion of 5- Fluorouracil Given Every Other Week in Adult Patients With Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 20 Jul 2018
At a glance
- Drugs Pralatrexate (Primary) ; Fluorouracil
- Indications Solid tumours
- Focus Adverse reactions
- 13 Jul 2018 Status has been changed from recruiting to Completed
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 04 Aug 2015 Results published in the Cancer.